Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (7)
P 1 (6)
P 2 (1)
P 3 (2)

Trial Status

Completed13
Unknown3
Active Not Recruiting2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT05374187Not ApplicableCompletedPrimary

Efficacy of Trigeminal Nerve Stimulation for ADHD

NCT07541820Not ApplicableActive Not Recruiting

Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder

NCT05165511Not ApplicableWithdrawn

Families, Responsibility, Education, Support, and Health for Executive Function

NCT05869253Not ApplicableCompletedPrimary

The Efficacy of Equine Assisted Occupational Therapy for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation

NCT04786730Phase 1CompletedPrimary

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

NCT04416360Not ApplicableCompleted

Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak

NCT04729439Phase 1Unknown

Technology-Enhanced Executive Functioning Intervention for ADHD

NCT01907360Phase 1CompletedPrimary

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

NCT01010750Phase 1CompletedPrimary

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT03371810Phase 2CompletedPrimary

Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder

NCT04229251Not ApplicableUnknownPrimary

Online Mindfulness-Based Intervention for ADHD

NCT03806946CompletedPrimary

Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder

NCT02827188Not ApplicableCompletedPrimary

Cognitive Restructuring in ADHD: Functional Training

NCT00339729CompletedPrimary

Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)

NCT01624649CompletedPrimary

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

NCT01886469Phase 1CompletedPrimary

A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT01357993Phase 3CompletedPrimary

A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder

NCT01323192Phase 3CompletedPrimary

An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder

NCT01657721Phase 1UnknownPrimary

Working Memory Training in ADHD (The Engage Study)

Showing all 19 trials

Research Network

Activity Timeline